---
title: "Thor Medical ASA: Share capital increase in relation to Subsequent Offering registered"
date: "2025-02-10 16:26:01"
summary: "10.2.2025 09:25:55 CET | Thor Medical ASA | Total number of voting rights andcapitalOslo, Norway, 10 February 2025: Reference is made to stock exchangeannouncements by Thor Medical ASA (the \"Company\") on 24 January 2025 regardingthe final results of a subsequent offering (the \"Subsequent Offering\"), whereatotal of 10,519,746 new shares in..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

10.2.2025 09:25:55 CET | Thor Medical ASA | Total number of voting rights andcapital

Oslo, Norway, 10 February 2025: Reference is made to stock exchangeannouncements by Thor Medical ASA (the "Company") on 24 January 2025 regardingthe final results of a subsequent offering (the "Subsequent Offering"), whereatotal of 10,519,746 new shares in the Company were allocated and resolvedissuedby the board of directors.

The share capital increase relating to the Subsequent Offering is nowregisteredwith the Norwegian Register of Business Enterprises. The Company's sharecapitalis after the registration NOK 62,881,704.20, divided into 314,408,521 shares.Each share has a nominal value of NOK 0.20 and represents one vote in theCompany's general meeting.

DISCLOSURE REGULATION

This information is required to be disclosed under Section 5-12 of theSecurities Trading Act.

CONTACTS

\* Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.no

ABOUT THOR MEDICAL ASA

Thor Medical is an emerging supplier of radionuclides, primarily alphaparticleemitters, from naturally occurring thorium. Its proprietary production processrequires no irradiation or use of nuclear reactors, and provides reliable,environmentally friendly, cost-efficient supply of alpha-emitters for theradiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norwayandlisted on the Oslo Stock Exchange under the ticker symbol 'TRMED'.

ATTACHMENTS

Download announcement as PDF.pdf -https://kommunikasjon.ntb.no/ir-files/17848634/18415420/5604/Download%20announcement%20as%20PDF.pdf

https://newsweb.oslobors.no/message/638120

[Reuters](https://www.tradingview.com/news/reuters.com,2025-02-10:newsml_Obis6wdQa:0-thor-medical-asa-share-capital-increase-in-relation-to-subsequent-offering-registered/)
